Analysis of the hippocampal proteome in ME7 prion disease reveals a predominant astrocytic signature and highlights the brain-restricted production of clusterin in chronic neurodegeneration

Journal of Biological Chemistry

Volumn 289, Issue 7, 2014, Pages 4532-4545

  Asuni, Ayodeji A ^a   Gray, Bryony ^a   Bailey, Joanne ^a   Skipp, Paul ^a   Perry, V Hugh ^a   O'Connor, Vincent ^a  

^a UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASTROCYTES; ITRAQ; MASS SPECTROMETRY (MS); ME7; MRNA; NEUROBIOLOGY; NEURODEGENERATION; PRION; PRIONS;

ALZHEIMER DISEASE; ANIMALS; ASTROCYTES; BIOLOGICAL MARKERS; CLUSTERIN; DISEASE MODELS, ANIMAL; FEMALE; HIPPOCAMPUS; HUMANS; MICE; NERVE TISSUE PROTEINS; PRION DISEASES; PROTEOME;

EID: 84894144588     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.502690     Document Type: Article

References (112)

1. Chiesa, R., Drisaldi, B., Quaglio, E., Migheli, A., Piccardo, P., Ghetti, B., and Harris, D. A. (2000) Accumulation of protease-resistant prion protein (PrP) and apoptosis of cerebellar granule cells in transgenic mice expressing a PrP insertional mutation. Proc. Natl. Acad. Sci. U.S.A. 97, 5574-5579
2. Muchowski, P. J. (2002) Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones? Neuron 35, 9-12
3. Morimoto, R. I. (2008) Proteotoxic stress and inducible chaperone networks in neurodegenerative disease and aging. Genes Dev. 22, 1427-1438
4. Aguzzi, A. (2004) Understanding the diversity of prions. Nat. Cell Biol. 6, 290-292
5. Caughey, B., and Baron, G. S. (2006) Prions and their partners in crime. Nature 443, 803-810
6. Kellett, K. A., and Hooper, N. M. (2009) Prion protein and Alzheimer disease. Prion 3, 190-194
7. Morris, R. J., Parkyn, C. J., and Jen, A. (2006) Traffic of prion protein between different compartments on the neuronal surface, and the propagation of prion disease. FEBS Lett. 580, 5565-5571
8. Prusiner, S. B. (1996) Molecular biology and genetics of prion diseases. Cold Spring Harbor Symp. Quant. Biol. 61, 473-493
9. Herms, J., Tings, T., Gall, S., Madlung, A., Giese, A., Siebert, H., Schürmann, P., Windl, O., Brose, N., and Kretzschmar, H. (1999) Evidence of presynaptic location and function of the prion protein. J. Neurosci. 19, 8866-8875
10. Williams, A., Lucassen, P. J., Ritchie, D., and Bruce, M. (1997) PrP deposition, microglial activation, and neuronal apoptosis in murine scrapie. Exp. Neurol. 144, 433-438
11. Grasbon-Frodl, E., Lorenz, H., Mann, U., Nitsch, R. M., Windl, O., and Kretzschmar, H. A. (2004) Loss of glycosylation associated with the T183A mutation in human prion disease. Acta Neuropathol. 108, 476-484
12. Yuan, J., Xiao, X., McGeehan, J., Dong, Z., Cali, I., Fujioka, H., Kong, Q., Kneale, G., Gambetti, P., and Zou, W. Q. (2006) Insoluble aggregates and protease-resistant conformers of prion protein in uninfected human brains. J. Biol. Chem. 281, 34848-34858
13. Taraboulos, A., Serban, D., and Prusiner, S. B. (1990) Scrapie prion proteins accumulate in the cytoplasm of persistently infected cultured cells. J. Cell Biol. 110, 2117-2132
14. Ilieva, H., Polymenidou, M., and Cleveland, D. W. (2009) Non-cell autonomous toxicity in neurodegenerative disorders: ALS and beyond. J. Cell Biol. 187, 761-772
15. Raeber, A. J., Race, R. E., Brandner, S., Priola, S. A., Sailer, A., Bessen, R. A., Mucke, L., Manson, J., Aguzzi, A., Oldstone, M. B., Weissmann, C., and Chesebro, B. (1997) Astrocyte-specific expression of hamster prion protein (PrP) renders PrP knockout mice susceptible to hamster scrapie. EMBO J. 16, 6057-6065
16. Teismann, P., and Schulz, J. (2004) Cellular pathology of Parkinson's disease: astrocytes, microglia and inflammation. Cell Tissue Res. 318, 149-161
17. Luccarini, I., Grossi, C., Traini, C., Fiorentini, A., Ed Dami, T., and Casamenti, F. (2012) A plaque-associated glial reaction as a determinant of apoptotic neuronal death and cortical gliogenesis: a study in APP mutant mice. Neurosci. Lett. 506, 94-99
18. DaRocha-Souto, B., Scotton, T. C., Coma, M., Serrano-Pozo, A., Hashimoto, T., Serenó, L., Rodríguez, M., Sánchez, B., Hyman, B. T., and Gómez-Isla, T. (2011) Brain oligomeric-amyloid but not total amyloid plaque burden correlates with neuronal loss and astrocyte inflammatory response in amyloid precursor protein/tau transgenic mice. J. Neuropathol. Exp. Neurol. 70, 360-376
19. Cunningham, C., Wilcockson, D. C., Boche, D., and Perry, V. H. (2005) Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease. J. Virol. 79, 5174-5184
20. Teeling, J. L., Felton, L. M., Deacon, R. M., Cunningham, C., Rawlins, J. N., and Perry, V. H. (2007) Sub-pyrogenic systemic inflammation impacts on brain and behavior, independent of cytokines. Brain Behav. Immun. 21, 836-850
21. Gómez-Nicola, D., Fransen, N. L., Suzzi, S., and Perry, V. H. (2013) Regulation of microglial proliferation during chronic neurodegeneration. J. Neurosci. 33, 2481-2493
22. Asuni, A. A., Hilton, K., Siskova, Z., Lunnon, K., Reynolds, R., Perry, V. H., and O'Connor, V. (2010)-Synuclein deficiency in the C57BL/6JOlaHsd strain does not modify disease progression in the ME7 model of prion disease. Neuroscience 165, 662-674
23. Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M., and Altman, D. G. (2010) Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research. J. Pharmacol. Pharmacother. 1, 94-99
24. Cunningham, C., Deacon, R., Wells, H., Boche, D., Waters, S., Diniz, C. P., Scott, H., Rawlins, J. N., and Perry, V. H. (2003) Synaptic changes characterize early behavioural signs in the ME7 model of murine prion disease. Eur. J. Neurosci. 17, 2147-2155
25. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B., Parker, K., Hattan, S., Khainovski, N., Pillai, S., Dey, S., Daniels, S., Purkayastha, S., Juhasz, P., Martin, S., Bartlet-Jones, M., He, F., Jacobson, A., and Pappin, D. J. (2004) Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 3, 1154-1169
26. Garland, P., Broom, L. J., Quraishe, S., Dalton, P. D., Skipp, P., Newman, T. A., and Perry, V. H. (2012) Soluble axoplasm enriched from injured CNS axons reveals the early modulation of the actin cytoskeleton. PLoS One 7, e47552
27. Choong, L. Y., Lim, S., Chong, P. K., Wong, C. Y., Shah, N., and Lim, Y. P. (2010) Proteome-wide profiling of the MCF10AT breast cancer progression model. PLoS One 5, e11030
28. Gan, C. S., Chong, P. K., Pham, T. K., and Wright, P. C. (2007) Technical, experimental, and biological variations in isobaric tags for relative and absolute quantitation (iTRAQ). J. Proteome Res. 6, 821-827
29. Gill, C., Parkinson, E., Church, M. K., Skipp, P., Scott, D., White, A. J., O'Connor, C. D., and Clough, G. F. (2011) A qualitative and quantitative proteomic study of human microdialysate and the cutaneous response to injury. AAPS J. 13, 309-317
30. Chen, Y., Choong, L.-Y., Lin, Q., Philp, R., Wong, C.-H., Ang, B.-K., Tan, Y.-L., Loh, M.-C., Hew, C.-L., Shah, N., Druker, B. J., Chong, P.-K., and Lim, Y.-P. (2007) Differential expression of novel tyrosine kinase substrates during breast cancer development. Mol. Cell. Proteomics 6, 2072-2087
31. Asuni, A. A., Cunningham, C., Vigneswaran, P., Perry, V. H., and O'Connor, V. (2008) Unaltered SNARE complex formation in an in vivo model of prion disease. Brain Res. 1233, 1-7
32. Gray, B. C., Siskova, Z., Perry, V. H., and O'Connor, V. (2009) Selective presynaptic degeneration in the synaptopathy associated with ME7 induced hippocampal pathology. Neurobiol. Dis. 35, 63-74
33. Gray, B. C. (2006) Evidence for Synaptic Dysfunction in Prion Disease. Ph.D. thesis, School of Biological Sciences, University of Southampton, Southampton, UK
34. Power, J. H., Asad, S., Chataway, T. K., Chegini, F., Manavis, J., Temlett, J. A., Jensen, P. H., Blumbergs, P. C., and Gai, W. P. (2008) Peroxiredoxin 6 in human brain: molecular forms, cellular distribution, and association with Alzheimer's disease pathology. Acta Neuropathol. 115, 611-622
35. Pasinetti, G. M., Johnson, S. A., Oda, T., Rozovsky, I., and Finch, C. E. (1994) Clusterin (SGP-2): a multifunctional glycoprotein with regional expression in astrocytes and neurons of the adult rat brain. J. Comp. Neurol. 339, 387-400
36. Maragakis, N. J., Dietrich, J., Wong, V., Xue, H., Mayer-Proschel, M., Rao, M. S., and Rothstein, J. D. (2004) Glutamate transporter expression and function in human glial progenitors. Glia 45, 133-143
37. Wilhelmsson, U., Bushong, E. A., Price, D. L., Smarr, B. L., Phung, V., Terada, M., Ellisman, M. H., and Pekny, M. (2006) Redefining the concept of reactive astrocytes as cells that remain within their unique domains upon reaction to injury. Proc. Natl. Acad. Sci. U.S.A. 103, 17513-17518
38. Sofroniew, M. V. (2005) Reactive astrocytes in neural repair and protection. Neuroscientist 11, 400-407
39. Lepore, A. C., Dejea, C., Carmen, J., Rauck, B., Kerr, D. A., Sofroniew, M. V., and Maragakis, N. J. (2008) Selective ablation of proliferating astrocytes does not affect disease outcome in either acute or chronic models of motor neuron degeneration. Exp. Neurol. 211, 423-432
40. Burkey, B. F., deSilva, H. V., and Harmony, J. A. (1991) Intracellular processing of apolipoprotein J precursor to the mature heterodimer. J. Lipid Res. 32, 1039-1048
41. Thambisetty, M., Simmons, A., Velayudhan, L., Hye, A., Campbell, J., Zhang, Y., Wahlund, L. O., Westman, E., Kinsey, A., Güntert, A., Proitsi, P., Powell, J., Causevic, M., Killick, R., Lunnon, K., Lynham, S., Broadstock, M., Choudhry, F., Howlett, D. R., Williams, R. J., Sharp, S. I., Mitchelmore, C., Tunnard, C., Leung, R., Foy, C., O'Brien, D., Breen, G., Furney, S. J., Ward, M., Kloszewska, I., Mecocci, P., Soininen, H., Tsolaki, M., Vellas, B., Hodges, A., Murphy, D. G., Parkins, S., Richardson, J. C., Resnick, S. M., Ferrucci, L., Wong, D. F., Zhou, Y., Muehlboeck, S., Evans, A., Francis, P. T., Spenger, C., and Lovestone, S. (2010) Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch. Gen. Psychiatry 67, 739-748
42. Püntener, U., Booth, S. G., Perry, V. H., and Teeling, J. L. (2012) Longterm impact of systemic bacterial infection on the cerebral vasculature and microglia. J. Neuroinflammation 9, 146
43. Sisková, Z., Page, A., O'Connor, V., and Perry, V. H. (2009) Degenerating synaptic boutons in prion disease: microglia activation without synaptic stripping. Am. J. Pathol. 175, 1610-1621
44. Jeffrey, M., Fraser, J. R., Halliday, W. G., Fowler, N., Goodsir, C. M., and Brown, D. A. (1995) Early unsuspected neuron and axon terminal loss in scrapie-infected mice revealed by morphometry and immunocytochemistry. Neuropathol. Appl. Neurobiol. 21, 41-49
45. Pan, T., Wong, P., Chang, B., Li, C., Li, R., Kang, S. C., Wisniewski, T., and Sy, M. S. (2005) Biochemical fingerprints of prion infection: accumulations of aberrant full-length and N-terminally truncated PrP species are common features in mouse prion disease. J. Virol. 79, 934-943
46. DeSouza, L., Diehl, G., Rodrigues, M. J., Guo, J., Romaschin, A. D., Colgan, T. J., and Siu, K. W. (2005) Search for cancer markers from endometrial tissues using differentially labeled tags iTRAQ and cICAT with multidimensional liquid chromatography and tandem mass spectrometry. J. Proteome Res. 4, 377-386
47. Lafon-Cazal, M., Adjali, O., Galéotti, N., Poncet, J., Jouin, P., Homburger, V., Bockaert, J., and Marin, P. (2003) Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J. Biol. Chem. 278, 24438-24448
48. Yang, J. W., Rodrigo, R., Felipo, V., and Lubec, G. (2005) Proteome analysis of primary neurons and astrocytes from rat cerebellum. J. Proteome Res. 4, 768-788
49. Filali, H., Martin-Burriel, I., Harders, F., Varona, L., Serrano, C., Acín, C., Badiola, J. J., Bossers, A., and Bolea, R. (2012) Medulla oblongata transcriptome changes during presymptomatic natural scrapie and their association with prion-related lesions. BMC Genomics 13, 399
50. Brown, A. R., Webb, J., Rebus, S., Williams, A., and Fazakerley, J. K. (2004) Identification of up-regulated genes by array analysis in scrapie-infected mouse brains. Neuropathol. Appl. Neurobiol. 30, 555-567
51. Hwang, D., Lee, I. Y., Yoo, H., Gehlenborg, N., Cho, J. H., Petritis, B., Baxter, D., Pitstick, R., Young, R., Spicer, D., Price, N. D., Hohmann, J. G., Dearmond, S. J., Carlson, G. A., and Hood, L. E. (2009) A systems approach to prion disease. Mol. Syst. Biol. 5, 252
52. Cunningham, C., Wilcockson, D. C., Campion, S., Lunnon, K., and Perry, V. H. (2005) Central and systemic endotoxin challenges exacerbate the local inflammatory response and increase neuronal death during chronic neurodegeneration. J. Neurosci. 25, 9275-9284
53. Cronier, S., Laude, H., and Peyrin, J.-M. (2004) Prions can infect primary cultured neurons and astrocytes and promote neuronal cell death. Proc. Natl. Acad. Sci. U.S.A. 101, 12271-12276
54. Mallucci, G., Dickinson, A., Linehan, J., Klöhn, P. C., Brandner, S., and Collinge, J. (2003) Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis. Science 302, 871-874
55. Lima, F. R., Arantes, C. P., Muras, A. G., Nomizo, R., Brentani, R. R., and Martins, V. R. (2007) Cellular prion protein expression in astrocytes modulates neuronal survival and differentiation. J. Neurochem. 103, 2164-2176
56. Diedrich, J. F., Bendheim, P. E., Kim, Y. S., Carp, R. I., and Haase, A. T. (1991) Scrapie-associated prion protein accumulates in astrocytes during scrapie infection. Proc. Natl. Acad. Sci. U.S.A. 88, 375-379
57. Jeffrey, M., and González, L. (2004) Pathology and pathogenesis of bovine spongiform encephalopathy and scrapie. Curr. Top. Microbiol. Immunol. 284, 65-97
58. Kercher, L., Favara, C., Chan, C. C., Race, R., and Chesebro, B. (2004) Differences in scrapie-induced pathology of the retina and brain in transgenic mice that express hamster prion protein in neurons, astrocytes, or multiple cell types. Am. J. Pathol. 165, 2055-2067
59. Raeber, A. J., Sailer, A., Hegyi, I., Klein, M. A., Rülicke, T., Fischer, M., Brandner, S., Aguzzi, A., and Weissmann, C. (1999) Ectopic expression of prion protein (PrP) in T lymphocytes or hepatocytes of PrP knockout mice is insufficient to sustain prion replication. Proc. Natl. Acad. Sci. U.S.A. 96, 3987-3992
60. Race, R., Oldstone, M., and Chesebro, B. (2000) Entry versus blockade of brain infection following oral or intraperitoneal scrapie administration: role of prion protein expression in peripheral nerves and spleen. J. Virol. 74, 828-833
61. Schultz, J., Schwarz, A., Neidhold, S., Burwinkel, M., Riemer, C., Simon, D., Kopf, M., Otto, M., and Baier, M. (2004) Role of interleukin-1 in prion disease-associated astrocyte activation. Am. J. Pathol. 165, 671-678
62. Lewicki, H., Tishon, A., Homann, D., Mazarguil, H., Laval, F., Asensio, V. C., Campbell, I. L., DeArmond, S., Coon, B., Teng, C., Gairin, J. E., and Oldstone, M. B. (2003) T cells infiltrate the brain in murine and human transmissible spongiform encephalopathies. J. Virol. 77, 3799-3808
63. Nacerddine, K., Lehembre, F., Bhaumik, M., Artus, J., Cohen-Tannoudji, M., Babinet, C., Pandolfi, P. P., and Dejean, A. (2005) The SUMO pathway is essential for nuclear integrity and chromosome segregation in mice. Dev. Cell 9, 769-779
64. Seifert, G., Schilling, K., and Steinhäuser, C. (2006) Astrocyte dysfunction in neurological disorders: a molecular perspective. Nat. Rev. Neurosci. 7, 194-206
65. Omary, M. B., Coulombe, P. A., and McLean, W. H. (2004) Intermediate filament proteins and their associated diseases. N. Engl. J. Med. 351, 2087-2100
66. Baig, S., Palmer, L. E., Owen, M. J., Williams, J., Kehoe, P. G., and Love, S. (2012) ClusterinmRNAand protein in Alzheimer's disease. J. Alzheimers Dis. 28, 337-344
67. Charnay, Y., Imhof, A., Vallet, P. G., Kovari, E., Bouras, C., and Giannakopoulos, P. (2012) Clusterin in neurological disorders: molecular perspectives and clinical relevance. Brain Res. Bull. 88, 434-443
68. Matsubara, E., Soto, C., Governale, S., Frangione, B., and Ghiso, J. (1996) Apolipoprotein J and Alzheimer's amyloid solubility. Biochem. J. 316, 671-679
69. Boggs, L. N., Fuson, K. S., Baez, M., Churgay, L., McClure, D., Becker, G., and May, P. C. (1996) Clusterin (Apo J) protects against in vitro amyloid (1-40) neurotoxicity. J. Neurochem. 67, 1324-1327
70. Rosenberg, M. E., Girton, R., Finkel, D., Chmielewski, D., Barrie, A., 3rd, Witte, D. P., Zhu, G., Bissler, J. J., Harmony, J. A., and Aronow, B. J. (2002) Apolipoprotein J/clusterin prevents a progressive glomerulopathy of aging. Mol. Cell. Biol. 22, 1893-1902
71. Wyatt, A. R., Yerbury, J. J., Berghofer, P., Greguric, I., Katsifis, A., Dobson, C. M., and Wilson, M. R. (2011) Clusterin facilitates in vivo clearance of extracellular misfolded proteins. Cell. Mol. Life Sci. 68, 3919-3931
72. Sleegers, K., Lambert, J. C., Bertram, L., Cruts, M., Amouyel, P., and Van Broeckhoven, C. (2010) The pursuit of susceptibility genes for Alzheimer's disease: progress and prospects. Trends Genet. 26, 84-93
73. Schjeide, B. M., Schnack, C., Lambert, J. C., Lill, C. M., Kirchheiner, J., Tumani, H., Otto, M., Tanzi, R. E., Lehrach, H., Amouyel, P., von Arnim, C. A., and Bertram, L. (2011) The role of clusterin, complement receptor 1, and phosphatidylinositol binding clathrin assembly protein in Alzheimer disease risk and cerebrospinal fluid biomarker levels. Arch. Gen. Psychiatry 68, 207-213
74. Schrijvers, E. M., Koudstaal, P. J., Hofman, A., and Breteler, M. M. (2011) Plasma clusterin and the risk of Alzheimer disease. JAMA 305, 1322-1326
75. Xing, Y. Y., Yu, J. T., Cui, W. Z., Zhong, X. L., Wu, Z. C., Zhang, Q., and Tan, L. (2012) Blood clusterin levels, rs9331888 polymorphism, and the risk of Alzheimer's disease. J. Alzheimers Dis. 29, 515-519
76. IJsselstijn, L., Dekker, L. J., Koudstaal, P. J., Hofman, A., Sillevis Smitt, P. A., Breteler, M. M., and Luider, T. M. (2011) Serum Clusterin levels are not increased in presymptomatic Alzheimer's disease. J. Proteome Res. 10, 2006-2010
77. Schürmann, B., Wiese, B., Bickel, H., Weyerer, S., Riedel-Heller, S. G., Pentzek, M., Bachmann, C., Williams, J., van den Bussche, H., Maier, W., and Jessen, F. (2011) Association of the Alzheimer's disease clusterin risk allele with plasma clusterin concentration. J. Alzheimers Dis. 25, 421-424
78. Silajdžić, E., Minthon, L., Björkqvist, M., and Hansson, O. (2012) No diagnostic value of plasma clusterin in Alzheimer's disease. PLoS One 7, e50237
79. Campbell, I. L., Eddleston, M., Kemper, P., Oldstone, M. B., and Hobbs, M. V. (1994) Activation of cerebral cytokine gene expression and its correlation with onset of reactive astrocyte and acute-phase response gene expression in scrapie. J. Virol. 68, 2383-2387
80. Newsom, D. M., Liggitt, H. D., O'Rourke, K., Zhuang, D., Schneider, D. A., and Harrington, R. D. (2011) Cytokine antibody array analysis in brain and periphery of scrapie-infected Tg338 mice. Comp. Immunol. Microbiol. Infect. Dis. 34, 387-397
81. Gabay, C., and Kushner, I. (1999) Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340, 448-454
82. Petersen, H. H., Nielsen, J. P., and Heegaard, P. M. (2004) Application of acute phase protein measurements in veterinary clinical chemistry. Vet. Res. 35, 163-187
83. Witte, D. P., Aronow, B. J., Stauderman, M. L., Stuart, W. D., Clay, M. A., Gruppo, R. A., Jenkins, S. H., and Harmony, J. A. (1993) Platelet activation releases megakaryocyte-synthesized apolipoprotein J, a highly abundant protein in atheromatous lesions. Am. J. Pathol. 143, 763-773
84. Devauchelle, V., Essabbani, A., De Pinieux, G., Germain, S., Tourneur, L., Mistou, S., Margottin-Goguet, F., Anract, P., Migaud, H., Le Nen, D., Lequerré, T., Saraux, A., Dougados, M., Breban, M., Fournier, C., and Chiocchia, G. (2006) Characterization and functional consequences of underexpression of clusterin in rheumatoid arthritis. J. Immunol. 177, 6471-6479
85. Nilselid, A. M., Davidsson, P., Nägga, K., Andreasen, N., Fredman, P., and Blennow, K. (2006) Clusterin in cerebrospinal fluid: analysis of carbohydrates and quantification of native and glycosylated forms. Neurochem. Int. 48, 718-728
86. Přikrylová Vranová, H., Mareš, J., Nevrlý, M., Stejskal, D., Zapletalová, J., Hluštík, P., and Kaňovský, P. (2010) CSF markers of neurodegeneration in Parkinson's disease. J. Neural Transm. 117, 1177-1181
87. Stoop, M. P., Dekker, L. J., Titulaer, M. K., Burgers, P. C., Sillevis Smitt, P. A., Luider, T. M., and Hintzen, R. Q. (2008) Multiple sclerosis-related proteins identified in cerebrospinal fluid by advanced mass spectrometry. Proteomics 8, 1576-1585
88. Dieterle, F., Perentes, E., Cordier, A., Roth, D. R., Verdes, P., Grenet, O., Pantano, S., Moulin, P., Wahl, D., Mahl, A., End, P., Staedtler, F., Legay, F., Carl, K., Laurie, D., Chibout, S. D., Vonderscher, J., and Maurer, G. (2010) Urinary clusterin, cystatin C, 2-microglobulin and total protein as markers to detect drug-induced kidney injury. Nat. Biotechnol. 28, 463-469
89. Hazzaa, S. M., Elashry, O. M., and Afifi, I. K. (2010) Clusterin as a diagnostic and prognostic marker for transitional cell carcinoma of the bladder. Pathol. Oncol. Res. 16, 101-109
90. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D., and Perry, V. H. (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768-774
91. Fukuda, I., Ishihara, T., Ohmachi, S., Sakikawa, I., Morita, A., Ikeda, M., Yamane, S., Toyosaki-Maeda, T., Takinami, Y., Okamoto, H., Numata, Y., and Fukui, N. (2012) Potential plasma biomarkers for progression of knee osteoarthritis using glycoproteomic analysis coupled with a 2DLC-MALDI system. Proteome Sci. 10, 36
92. Yu, H. R., Kuo, H. C., Huang, E. Y., Liang, C. D., Hwang, K. P., Lin, I. C., Sheen, J. M., Wang, T. J., Wang, C. L., and Yang, K. D. (2010) Plasma clusterin levels in predicting the occurrence of coronary artery lesions in patients with Kawasaki disease. Pediatr. Cardiol. 31, 1151-1156
93. Beart, P. M., and O'Shea, R. D. (2007) Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br. J. Pharmacol. 150, 5-17
94. Lipton, S. A., Singel, D. J., and Stamler, J. S. (1994) Neuroprotective and neurodestructive effects of nitric oxide and redox congeners. Ann. N.Y. Acad. Sci. 738, 382-387
95. Foran, E., and Trotti, D. (2009) Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis. Antioxid. Redox Signal. 11, 1587-1602
96. Majer, A., Medina, S. J., Niu, Y., Abrenica, B., Manguiat, K. J., Frost, K. L., Philipson, C. S., Sorensen, D. L., and Booth, S. A. (2012) Early mechanisms of pathobiology are revealed by transcriptional temporal dynamics in hippocampal CA1 neurons of prion infected mice. PLoS Pathog. 8, e1003002
97. Hofmann, B., Hecht, H. J., and Flohé, L. (2002) Peroxiredoxins. Biol. Chem. 383, 347-364
98. Phelan, S. A., Wang, X., Wallbrandt, P., Forsman-Semb, K., and Paigen, B. (2003) Overexpression of Prdx6 reduces H2O2 but does not prevent diet-induced atherosclerosis in the aortic root. Free Radic. Biol. Med. 35, 1110-1120
99. Manevich, Y., and Fisher, A. B. (2005) Peroxiredoxin 6, a 1-Cys peroxiredoxin, functions in antioxidant defense and lung phospholipid metabolism. Free Radic. Biol. Med. 38, 1422-1432
100. Cunningham, C., Deacon, R. M., Chan, K., Boche, D., Rawlins, J. N., and Perry, V. H. (2005) Neuropathologically distinct prion strains give rise to similar temporal profiles of behavioral deficits. Neurobiol. Dis. 18, 258-269
101. Hilton, K. J., Cunningham, C., Reynolds, R. A., and Perry, V. H. (2013) Early hippocampal synaptic loss precedes neuronal loss and associates with early behavioural deficits in three distinct strains of prion disease. PLoS ONE 8, e68062
102. Kempster, S., Collins, M. E., Aronow, B. J., Simmons, M., Green, R. B., and Edington, N. (2004) Clusterin shortens the incubation and alters the histopathology of bovine spongiform encephalopathy in mice. Neuroreport 15, 1735-1738
103. Sasaki, K., Doh-ura, K., Ironside, J. W., and Iwaki, T. (2002) Increased clusterin (apolipoprotein J) expression in human and mouse brains infected with transmissible spongiform encephalopathies. Acta Neuropathol. 103, 199-208
104. Kopacek, J., Sakaguchi, S., Shigematsu, K., Nishida, N., Atarashi, R., Nakaoke, R., Moriuchi, R., Niwa, M., and Katamine, S. (2000) Upregulation of the genes encoding lysosomal hydrolases, a perforin-like protein, and peroxidases in the brains of mice affected with an experimental prion disease. J. Virol. 74, 411-417
105. Wagner, W., Reuter, A., Hüller, P., Löwer, J., and Wessler, S. (2012) Peroxiredoxin 6 promotes upregulation of the prion protein (PrP) in neuronal cells of prion-infected mice. Cell Commun. Signal. 10, 38
106. Liu, X., Rapp, N., Deans, R., and Cheng, L. (2000) Molecular cloning and chromosomal mapping of a candidate cytokine gene selectively expressed in human CD34+ cells. Genomics 65, 283-292
107. Larvie, M., Shoup, T., Chang, W.-C., Chigweshe, L., Hartshorn, K., White, M. R., Stahl, G. L., Elmaleh, D. R., and Takahashi, K. (2012) Mannose-binding lectin binds to amyloid protein and modulates inflammation. J. Biomed. Biotechnol. 2012, 1-12
108. Maccioni, R. B., and Cambiazo, V. (1995) Role of microtubule-associated proteins in the control of microtubule assembly. Physiol. Rev. 75, 835-864
109. Rashmi, R. N., Eckes, B., Glöckner, G., Groth, M., Neumann, S., Gloy, J., Sellin, L., Walz, G., Schneider, M., Karakesisoglou, I., Eichinger, L., and Noegel, A. A. (2012) The nuclear envelope protein Nesprin-2 has roles in cell proliferation and differentiation during wound healing. Nucleus 3, 172-186
110. Chueh, F. Y., Leong, K. F., Cronk, R. J., Venkitachalam, S., Pabich, S., and Yu, C. L. (2011) Nuclear localization of pyruvate dehydrogenase complex-E2 (PDC-E2), a mitochondrial enzyme, and its role in signal transducer and activator of transcription 5 (STAT5)-dependent gene transcription. Cell. Signal. 23, 1170-1178
111. Chung, C., and Raingo, J. (2013) Vesicle dynamics: how synaptic proteins regulate different modes of neurotransmission. J. Neurochem. 126, 146-154
112. Südhof, T. C. (2002) Synaptotagmins: Why So Many? J. Biol. Chem. 277, 7629-7632